Notice ID: cc30712f220748248369bc7368efe7a4Combined Synopsis/Solicitation
FY25 Vaccines for Children
Archived on February 14, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 1:00 PM UTC−05:00
- Posted
- January 17, 2025
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION
Notice details
- Office
- CDC OFFICE OF ACQUISITION SERVICES
- Place of performance
- Atlanta, GA, 30341
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Jan 23, 2026
Identifiers
- Solicitation number
- 75D30125R00065
- Notice ID
- cc30712f220748248369bc7368efe7a4
Description
The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA 93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.
Award Overview
No prior contract identified
No matching prior contract was found within an 18-month window using the same agency, NAICS, place-of-performance state, and PSC. This may be a new requirement, or the prior award uses a different classification.
Contacts
Documents
Select documents to download
Showing 3 of 3 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jan 17, 2025 | - | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jan 17, 2025 | - | |||
| Combined Synopsis/Solicitation | CENTERS FOR DISEASE CONTROL AND PREVENTION | Jan 17, 2025 | - |
Lifecycle
Solicitation:
75D30125R00065- Combined Synopsis
- 3×Combined SynopsisCurrentJan 16, 2025
FY25 Vaccines for Children
Similar Opportunities
Title | Phase | Deadline |
|---|---|---|
Additional Details
Solicitation Number
75D30125R00065
Archive Date
Feb 14, 2025
Office Address
ATLANTA, GA, 30333